Title Gliflozino Module 1_T2DM_T395_20250209 Day 3.pdf ✅

Diabetes Module Gliflozino Induction Training By: Rawda Mahmoud MSL 09 -02 -2025 GLIFL. Diab_T395_20250209
Module Items: Management of T2DM T2DM Diabetes Introduction Glucose Metabolism Guidelines Dapagliflozin Clinical trials
Clinical Trial Glossary Types of trial Experimental Randomized Controlled Nonrandomized Observational Cohort study Case-control Cross-sectional
Abbreviation Meaning Double Blind A clinical trial in which neither the medical staff nor the person knows which of several possible therapies the person is receiving. Double-dummy A technique for retaining the blind when administering supplies in a clinical trial, when the two treatments cannot be made identical. Open label study A type of study in which both the health providers and the patients are aware of the drug or treatment being given. Eligibility criteria In clinical trials, requirements that must be met for an individual to be included in a study Inclusion/exclusion criteria The medical or social standards determining whether a person may or may not be allowed to enter a clinical trial. These criteria are based on such factors as age, gender, the type and stage of a disease, previous treatment history, and other medical conditions. Endpoint Overall outcome that the protocol is designed to evaluate. Intent to treat Analysis of clinical trial results that includes all data from participants in the groups to which they were randomized even if they never received the treatment. Adverse effect An unwanted side effect of treatment Non-inferiority trial trial with the primary objective of showing that the response to the investigational product is not clinically inferior to a comparative agent (active or placebo control).